If you could vote on Brexit now which option would you choose?
   

EU authorizes 2 medicines for people at risk of severe COVID


The European Medicines Agency has recommended the authorization of two new medicines against the coronavirus for people at risk of severe disease. In a statement on Thursday, the EU drug regulator said it had concluded that the monoclonal antibody treatments — a combination of casirivimab and imdevimab, and the drug regdanvimab — have both been proven to significantly reduce the risk of hospitalization and death in patients vulnerable to serious COVID-19. The EMA described the safety profile of both medicines as “favorable,” and said that despite a small number of side effects, “the medicines’ benefits are greater than their risks.” The drug combination of casirivimab and imdevimab is made by Roche; it was granted an emergency use license by the U.S. Food and Drug Administration last November.

The Associated Press - November 11, 2021

View the full story here: https://apnews.com/article/coronavirus-pandemic-business-europe-health-d18748f4b4578410365b44e17aa9b734